Triterpenoids are a large and medicinally important group
of natural
products with a wide range of biological and pharmacological effects.
Among them, malabaricane-type triterpenoids are a rare group of terpenoids
with a 6,6,5-tricyclic ring system, and a few malabaricane triterpene
synthases have been characterized to date. Here, an arabidiol synthase
AmAS for the formation of the malabaricane-type 6,6,5-tricyclic triterpenoid
skeleton in astramalabaricosides biosynthesis was characterized from Astragalus membranaceus. Multiple sequence alignment, site-directed
mutagenesis, and molecular docking of AmAS reveal that residues Q256
and Y258 are essential for AmAS activity, and the triad motif IIH725-727
was the critical residue necessary for its product specificity. Mutation
of IIH725-727 with VFN led to the formation of seven tricyclic, tetracyclic,
and pentacyclic triterpenoids (1–7). Glycosylation of malabaricane-type triterpenoids in the biosynthesis
of astramalabaricosides was also explored. Three triterpenoids (1, 5, and 6) displayed potent inhibitory
effects against influenza A virus in vitro. These findings provide
insights into malabaricane-type triterpenoids biosynthesis in A. membranaceus and access to diverse bioactive triterpenoids
for drug discovery.